Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7

Songkai Sun; Boshi Huang; Zhuo Li; Zhao Wang; Lin Sun; Ping Gao; Dongwei Kang; Chin‐Ho Chen; Kuo‐Hsiung Lee; Dirk Daelemans; De Clercq Erik; Christophe Pannecouque; Peng Zhan; Xinyong Liu

doi:10.1016/j.bmcl.2020.127287

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Discovery, optimization, and target identification of novel coumarin derivatives as HIV-1 reverse transcriptase-associated ribonuclease H inhibitors

Dongwei Kang, Çagil Urhan, Fenju Wei, Estrella Frutos-Beltrán, Lin Sun, Mar Álvarez, Da Feng, Yucen Tao, Christophe Pannecouque, De Clercq Erik, Luis Menéndez‐Arias, Xinyong Liu, Peng Zhan

Article1991

New antiviral target on HIV-1 reverse transcriptase revealed by TIBO derivatives

Zeger Debyser, Rudi Pauwels, K Andries, Jan Desmyter, Michael J. Kukla, Paj Janssen, De Clercq Erik

Article2015

Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase

Won-Gil Lee, Kathleen M. Frey, Ricardo Gallardo‐Macias, Krasimir A. Spasov, Albert H. Chan, Karen S. Anderson, William L. Jorgensen

Bioorganic & Medicinal Chemistry Letters

Article1992

Specific HIV-1 Reverse Transcriptase Inhibitors

Zeger Debyser, Rudi Pauwels, Koen Andries, De Clercq Erik

Article2001

Pyridazines 92. Synthesis of dialkyldipyridazinodiazepinones as potential HIV‐1 reverse transcriptase inhibitors

Gottfried Heinisch, Barbara Matuszczak, Elisabeth Spielmann, Myriam Witvrouw, Christophe Pannecouque, De Clercq Erik